Skip to main content
. 2021 May 2;21(6):680–691. doi: 10.1111/papr.13008

TABLE 3.

Summary of Secondary Outcomes Over Time for Permanently Implanted Patients

Baseline 3‐Month 12‐Month 24‐Month
BPI
N 50 45 43 38
Mean severity score (SD) 6.8 (1.1) 3.3 (2.0) 3.1 (2.1) 2.8 (2.6)
Mean change from baseline, severity score (SD, P value) 3.5 (1.7, P < 0.001) 3.6 (1.9, P < 0.001) 3.9 (2.9, P < 0.001)
Mean interference score (SD) 7.1 (1.6) 3.5 (2.7) 3.2 (2.6) 2.7 (2.8)
Mean change from baseline, interference score (SD, P value) 3.5 (2.6, P < 0.001) 3.8 (2.8, P < 0.001) 4.2 (3.0, P < 0.001)
EQ‐5D‐5L
N 50 45 43 38
Mean EQ index score (SD) 0.404 (0.215) 0.637 (0.193) 0.633 (0.223) 0.645 (0.277)
Mean change from baseline, EQ index score (SD, P value) 0.233 (0.245, P < 0.001) 0.214 (0.213, P < 0.001) 0.221 (0.288, P < 0.001)
Minimally important difference from baseline, EQ index score (≥ 0.074) % 80.0 88.4 81.6
Mean EQ Health VAS score (SD) 53.3 (20.6) 73.2 (16.9) 71.4 (21.9) 77.1 (21.1)
Mean change from baseline, EQ Health VAS (SD, P value) 18.4 (25.1, P < 0.001) 17.4 (26.8, P < 0.001) 22.2 (31.4, P < 0.001)
ODI
N 50 44 43 38
Mean ODI score (SD) 52.3 (12.3) 34.6 (13.7) 31.2 (16.1) 31.5 (20.7)
Mean change from baseline, ODI score (SD, P value) 17.1 (11.9, P < 0.001) 20.3 (13.9, P < 0.001) 18.4 (20.3, P < 0.001)
Minimum detectable change from baseline, ODI (≥ 10%) % 70.5 76.7 71.1
PSQI
N 50 45 42 38
Mean PSQI score (SD) 12.0 (4.2) 8.4 (4.4) 8.6 (5.4) 7.8 (5.0)
Mean change from baseline, PSQI global score (SD, P value) 3.5 (4.6, P < 0.001) 3.1 (4.5, P < 0.001) 3.8 (5.0, P < 0.001)
Clinically meaningful change from baseline (reduction ≥ 3 from baseline) % 64.4 52.4 57.9

P values resulting from paired t‐test that the mean change from baseline was significantly different from 0 with an alpha of 0.05.

Abbreviations: BPI, Brief Pain Inventory; EQ‐5D‐5L, EuroQOL instrument; ODI, Oswestry Disability Index; PSQI, Pittsburgh Sleep Quality Index; SD, standard deviation; VAS, visual analogue scale.